We are live on ! Find out more
ADIM

Alpha DNA Investment Management Portfolio holdings

AUM $8.98M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
-1.44%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
10 Year Est. Return
AUM
$244M
AUM Growth
-$55.3M
Cap. Flow
-$44.9M
Cap. Flow %
-18.39%
Top 10 Hldgs %
47.87%
Holding
229
New
82
Increased
25
Reduced
61
Closed
60

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$2.17M
2
PM icon
Philip Morris
PM
+$1.84M
3
CL icon
Colgate-Palmolive
CL
+$1.83M
4
RTX icon
RTX Corp
RTX
+$1.82M
5
PG icon
Procter & Gamble
PG
+$1.81M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$2.5M
2
KO icon
Coca-Cola
KO
+$1.81M
3
MRK icon
Merck
MRK
+$1.72M
4
ACN icon
Accenture
ACN
+$1.23M
5
XOM icon
ExxonMobil
XOM
+$1.22M

Sector Composition

Rank Sector Weight
1 Technology 13.37%
2 Healthcare 12.44%
3 Financials 8.73%
4 Consumer Staples 6.45%
5 Industrials 6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BILL icon
176
BILL Holdings
BILL
$4.93B
-7,226
Closed -$844K
CALX icon
177
Calix
CALX
$2.49B
-16,967
Closed -$847K
CARG icon
178
CarGurus
CARG
$3.22B
-34,960
Closed -$791K
CHCO icon
179
City Holding Co
CHCO
$2.06B
-8,186
Closed -$737K
CNC icon
180
Centene
CNC
$32.1B
-17,030
Closed -$1.15M
CNK icon
181
Cinemark Holdings
CNK
$4.25B
-46,533
Closed -$768K
COHU icon
182
Cohu
COHU
$2.5B
-18,113
Closed -$753K
DKNG icon
183
DraftKings
DKNG
$12.6B
-31,373
Closed -$834K
EMR icon
184
Emerson Electric
EMR
$91.7B
-11,949
Closed -$1.08M
FATE icon
185
Fate Therapeutics
FATE
$319M
-147,651
Closed -$703K
FFBC icon
186
First Financial Bancorp
FFBC
$3.57B
-39,332
Closed -$804K
FIVN icon
187
FIVE9
FIVN
$2.44B
-9,815
Closed -$809K
FTNT icon
188
Fortinet
FTNT
$119B
-15,683
Closed -$1.19M
FVRR icon
189
Fiverr
FVRR
$315M
-28,536
Closed -$742K
GENI icon
190
Genius Sports
GENI
$2.16B
-123,125
Closed -$762K
GTLB icon
191
GitLab
GTLB
$7.11B
-14,678
Closed -$750K
GXO icon
192
GXO Logistics
GXO
$5.37B
-12,516
Closed -$786K
HAL icon
193
Halliburton
HAL
$28.2B
-34,819
Closed -$1.15M
HIMS icon
194
Hims & Hers Health
HIMS
$7.12B
-86,031
Closed -$809K
HQY icon
195
HealthEquity
HQY
$8.83B
-12,613
Closed -$796K
HRMY icon
196
Harmony Biosciences
HRMY
$2.3B
-20,242
Closed -$712K
HUBB icon
197
Hubbell
HUBB
$27.5B
-3,425
Closed -$1.14M
HXL icon
198
Hexcel
HXL
$7.6B
-11,000
Closed -$836K
IOT icon
199
Samsara
IOT
$23.5B
-28,461
Closed -$789K
LADR
200
Ladder Capital
LADR
$1.26B
-76,058
Closed -$825K

Similar funds

Alpha DNA Investment Management's Q3 2023 Portfolio in Review

As of Q3 2023, Alpha DNA Investment Management held 229 positions worth $244M, down 18% from $300M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Alpha DNA Investment Management withdrew a net $44.9M in Q3 2023, closing 60 positions and reducing 61 holdings. Its most notable exit was Parker-Hannifin, an estimated $1.21M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Alpha DNA Investment Management opened a new position in Becton Dickinson worth $2.07M.

  • Alpha DNA Investment Management's largest Q3 2023 buy was Becton Dickinson: 8,016 shares worth $2.07M.
  • Alpha DNA Investment Management added most to Microsoft in Q3 2023, an estimated $1.03M increase.
  • Alpha DNA Investment Management's biggest Q3 2023 reduction was Visa, cutting an estimated $2.5M.
  • Alpha DNA Investment Management fully exited Parker-Hannifin in Q3 2023, selling an estimated $1.21M.
  • Alpha DNA Investment Management's ten largest holdings make up 48% of its $244M portfolio in Q3 2023.
  • Alpha DNA Investment Management opened 82 new positions and closed 60 in Q3 2023.
  • Alpha DNA Investment Management's portfolio value fell 18% quarter-over-quarter to $244M.

Based on Alpha DNA Investment Management's 13F filing for Q3 2023, filed 7 Nov 2023.